A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial
Top Cited Papers
- 1 January 2005
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 3 (1), 103-111
- https://doi.org/10.1111/j.1538-7836.2004.01100.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The Pharmacology and Management of the Vitamin K AntagonistsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2004
- Prevention of Venous ThromboembolismSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2004
- Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO IJournal of Thrombosis and Haemostasis, 2004
- The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS studyJournal of Thrombosis and Haemostasis, 2003
- Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trialThe Lancet, 2002
- Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic SurgeryA Meta-analysis of 4 Randomized Double-blind StudiesArchives of Internal Medicine, 2002
- Optimization of ascending phlebography of the leg for screening of deep vein thrombosis in thromboprophylactic trialsActa Radiologica, 1997
- Phlebographic Findings in Venous Thrombosis following Total Hip ReplacementActa Radiologica, 1990
- Ventilation-perfusion studies in suspected pulmonary embolismAmerican Journal of Roentgenology, 1979
- Roentgen Diagnosis of Venous Thrombosis in the LegArchives of Surgery, 1972